Linzess (Allergan, Inc)
Welcome to the PulseAid listing for the Linzess drug offered from Allergan, Inc. This Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc |
| NON-PROPRIETARY NAME: | linaclotide |
| SUBSTANCE NAME: | LINACLOTIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-09-08 |
| END MARKETING DATE: | 0000-00-00 |
Linzess HUMAN PRESCRIPTION DRUG Details:
| Item Description | Linzess from Allergan, Inc |
| LABELER NAME: | Allergan, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 145(ug/1) |
| START MARKETING DATE: | 2012-09-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0456-1201_063e5e81-d821-4bc3-853c-95f5dca1546a |
| PRODUCT NDC: | 0456-1201 |
| APPLICATION NUMBER: | NDA202811 |
Other LINACLOTIDE Pharmaceutical Manufacturers / Labelers:
